24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Molecular and biochemical basis <strong>of</strong> disease<br />

to 0 .00008) . The strongest signals emerged from the haploblock harboring<br />

the trait-associated STR .<br />

These data provide further evidence for involvement <strong>of</strong> RELN gene<br />

variations in cognitive functions .<br />

P06.252<br />

the risk <strong>of</strong> respiratory distress syndrome in neonates from<br />

Bashkortostan, Russia and gene polymorphisms <strong>of</strong> cytochrome<br />

P450 (CYP A , CYP A ) and glutathione-s-transferase M<br />

(GSTM )<br />

L. Khamidullina1 , K. Danilko2 , R. Fayzullina2 , T. Victorova1 ;<br />

1 2 Institute <strong>of</strong> Biochemistry and <strong>Genetics</strong>, Ufa, Russian Federation, Bashkortostan<br />

State Medical University, Ufa, Russian Federation.<br />

We have investigated association between polymorphisms <strong>of</strong> cytochrome<br />

P450 genes (CYP1A1 (A2455G, T3801C), CYP1A2 (A-163C,<br />

T-2467delT)), glutathione-S-transferase M1 (deletion GSTM1) and risk<br />

<strong>of</strong> developing respiratory distress syndrome (RDS) in neonates from<br />

Bashkortostan .<br />

After birth molecular oxygen and free radicals influence on the neonates<br />

lung . They are potentially harmful to cellular components . Antioxidants<br />

provide protection against oxidative damage to proteins,<br />

lipids and DNA .<br />

We used whole peripheral blood <strong>of</strong> 144 patients with RDS and umbilical<br />

cord blood <strong>of</strong> 217 healthy term neonates for the isolation <strong>of</strong> genomic<br />

DNA. It was used PCR amplification. We used chi-square tests to detect<br />

the association between genes polymorphisms and RDS babies .<br />

It was shown that the CYP1A1 (T3801C) gene genotypes frequency<br />

distribution patterns not significantly differ between patients with RDS<br />

and healthy neonates (χ2 =1 .92, df=2, P=0 .382) . In male infants the<br />

CYP1A1 TC genotype was associated with higher risk <strong>of</strong> RDS (38 .1%<br />

in patients vs. 20.5% in healthy babies; χ2 =6 .8, P=0 .009; OR=2 .39,<br />

95%CI 1 .23-4 .68) . While, the CYP1A1 TT genotype had a protective<br />

effect (60.7% vs. 78.7%; χ2 =7 .0 P=0 .009; OR=0 .41, 95%CI 0 .22-<br />

0 .81) .<br />

But at the same time we found no differences in the genotypes frequency<br />

distributions <strong>of</strong> the CYP1A1(A2455G), CYP1A2 genes within<br />

the patients and healthy groups .<br />

We also didn’t find any association <strong>of</strong> GSTM1 gene with RDS .<br />

Our results showed that the polymorphisms in CYP1A1 may play a<br />

significant role in the development <strong>of</strong> RDS in male neonates.<br />

P06.253<br />

Genetic diagnosis <strong>of</strong> autosomal dominant and recessive<br />

Retinitis Pigmentosa using sNP high-throughput genotyping<br />

E. Pomares 1,2 , G. Marfany 1,3 , R. Gonzàlez-Duarte 1,2 ;<br />

1 Dept. de Genètica. Universitat de <strong>Barcelona</strong>, <strong>Barcelona</strong>, Spain, 2 CIBERER.<br />

Instituto de Salud Carlos III, <strong>Barcelona</strong>, Spain, 3 IBUB. Universitat de <strong>Barcelona</strong>,<br />

<strong>Barcelona</strong>, Spain.<br />

Retinitis Pigmentosa (RP), the major cause for blindness in the adults,<br />

is an extremely heterogeneous monogenic disorder which shows all<br />

mendelian types <strong>of</strong> inheritance . Up to now, more than 30 RP genes<br />

have been described, 17 <strong>of</strong> which are involved in autosomal dominant<br />

(adRP) and 20 in autosomal recessive (arRP) forms . However, many<br />

cases remain unassigned . Proper genetic diagnosis <strong>of</strong> the patients<br />

and potential carriers requires screening <strong>of</strong> all the candidates, but the<br />

high number <strong>of</strong> genes, with no major mutation sites, makes conventional<br />

mutation analysis time-consuming and costly for a small/medium<br />

sized laboratory . In addition, before undertaking the search for new<br />

RP genes, the already known candidates have to be ruled out . Taking<br />

into account these data and the fact that there is increasing evidence<br />

assigning the same candidate genes as responsible for distinct<br />

retinal dystrophies, we have designed an innovative time-cost effective<br />

strategy for cosegregation analysis <strong>of</strong> 39 RP and LCA genes by SNP<br />

genotyping on isolated families . This high-throughput strategy allows<br />

to discard the genes that do not cosegregate with the disease and<br />

highlights the remaining candidates . Subsequent mutational screening<br />

has allowed us to identify the causative mutations for several families .<br />

This type <strong>of</strong> analysis is very powerful in the arRP forms, particularly<br />

when the family is consanguineous . For adRP families, the analysis <strong>of</strong><br />

several affected siblings is usually informative enough to discard most<br />

<strong>of</strong> the candidates . This approach can also be successfully applied to<br />

diseases with high genetic heterogeneity .<br />

P06.254<br />

Genomewide Linkage validation <strong>of</strong> the RP locus and<br />

molecular Evaluation <strong>of</strong> Forty three candidate Genes<br />

J. Pieras 1,2 , M. Abd El-Aziz 3 , I. Barragan 1,2 , C. O’Driscoll 3 , S. Borrego 1,2 , L. Abu<br />

Safieh 3 , M. El-Ashry 3 , N. Carter 4 , C. Ponting 5 , S. Bhattacharya 3 , G. Antiñolo 1,2 ;<br />

1 Unidad de gestión Clínica de Genética, Reproducción y Medicina Fetal, Hospitales<br />

Universitarios Virgen del Rocío, Sevilla, Spain, 2 Centro de Investigación<br />

Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Seville, Spain,<br />

3 Department <strong>of</strong> Molecular <strong>Genetics</strong>, Institute <strong>of</strong> Ophthalmology, London, United<br />

Kingdom, 4 The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus,<br />

Hinxton, Cambridge, United Kingdom, 5 The Medical Research Council<br />

Functional <strong>Genetics</strong> Unit, Department <strong>of</strong> Physiology, Anatomy and <strong>Genetics</strong>,<br />

University <strong>of</strong> Oxford, Oxford, United Kingdom.<br />

RP25locus (Chr.6:56.02-89.78Mb) was identified as the genetic cause<br />

in 14% <strong>of</strong> autosomal recessive Retinitis Pigmentosa (RP) in Spain .<br />

Linkage analysis has also reported the presence <strong>of</strong> this locus in Pakistani<br />

and Chinese families .<br />

Our objective was: to confirm the initial findings <strong>of</strong> linkage to RP25locus<br />

by genomewide linkage analysis; mutation screening <strong>of</strong> genes from<br />

the RP25 region in 6 Spanish families with autosomal recessive RP<br />

(arRP) linked to this locus; analysis <strong>of</strong> new arRP families by microsatellite<br />

markers spanning the chromosome 6p12 .1q15 .<br />

The data obtained using the 10KGeneChip-Mapping array have confirmed<br />

the original evidence <strong>of</strong> linkage to only the RP25locus in the<br />

three families with no linkage to any other region in the genome . Targeted<br />

linkage analysis <strong>of</strong> 18 newly ascertained arRP families led to<br />

the identification <strong>of</strong> five additional Spanish families also linked to RP-<br />

25locus .<br />

Bioinformatics analysis <strong>of</strong> the RP25 region indicated in excess <strong>of</strong> 111<br />

genes with many showing retinal expression . 43 candidate genes were<br />

selected on the basis <strong>of</strong> their function, tissue expression pattern and/or<br />

the genetic data .<br />

The direct sequence analysis from these genes (38,7%) led to the<br />

identification <strong>of</strong> 244 Single Nucleotide Polymorphisms, <strong>of</strong> which 76<br />

were novel .<br />

In conclusion, the fact that none <strong>of</strong> the observed variants were pathogenic<br />

exclude the screened genes as disease causing in these families<br />

. However, we could not rule out these genes as good candidates<br />

for other retinal degenerations mapping to the same chromosomal<br />

region .<br />

These results support and validate the high prevalence <strong>of</strong> RP25 in the<br />

Spanish population .<br />

P06.255<br />

Retinoblastoma and microdeletion syndrome: identification <strong>of</strong><br />

PcDH8 as a candidate for developmental delay<br />

C. Dehainault1 , D. Michaux1 , L. Castera1 , I. Aerts1 , L. Desjardins1 , D. Stoppa-<br />

Lyonnet1,2 , M. Gauthier-Villars1 , C. Houdayer1,3 ;<br />

1 2 Institut Curie, Paris, France, INSERM U830 Université Paris Descartes, Paris,<br />

France, 3UMR INSERM 745 Université Paris Descartes, Paris, France.<br />

Retinoblastoma (RB), the most common pediatric intraocular neoplasm,<br />

results from inactivation <strong>of</strong> both alleles <strong>of</strong> the RB1 gene, located<br />

in 13q14 .2 . Whole germline RB1 gene deletions represent 6<br />

% <strong>of</strong> RB1 mutational spectrum . When the deletion involves the RB1<br />

flanking regions it also causes a variable degree <strong>of</strong> mental retardation<br />

and several dysmorphic abnormalities .<br />

In order to refine the role <strong>of</strong> chromosomal regions adjacent to RB1 in<br />

mental retardation and developmental delay, we decided to map the<br />

breakpoints in seven RB patients harbouring a whole gene deletion .<br />

Five <strong>of</strong> these patients presented no associated clinical abnormality,<br />

one presented a mild developmental delay with epileptic seizures, and<br />

one presented developmental delay with facial dysmorphism .<br />

To precisely map the deletion breakpoints we designed a 385 000 oligos-custom<br />

array (Nimblegen) focusing on RB1 and its flanking regions<br />

(34-74Mb) . We also used MP/LC, a multiplex semi quantitative<br />

PCR assay running on a DHPLC platform to further narrow the breakpoint<br />

regions . Then PCRs spanning the breakpoints were performed<br />

and sequenced which allowed the deletion breakpoints to be defined<br />

at the nucleotide level .<br />

We compared the deleted intervals between RB-only patients and RB<br />

patients with developmental delay and define a 3Mb critical interval<br />

that includes a good candidate, protocadherin 8 (PCDH8) . PCDH8 is<br />

thought to function in signalling pathways and cell adhesion in a cen-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!